19 July 2022
: Case report
Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review
Challenging differential diagnosis, Management of emergency care, Patient complains / malpractice, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Kazuhiro Ishikawa1ABCDEF*, Tomoaki Nakamura
DOI: 10.12659/AJCR.936889
Am J Case Rep 2022; 23:e936889
Table 1. MINO, TMP-SMX, LVFX, and CAZ were susceptible to Stenotrophomonas maltophilia.
Antibiotics | MIC (μg/mL) | Susceptibility |
---|---|---|
MINO | ≤2 | S |
TMP-SMX | ≤2 | S |
LVFX | ≤0.5 | S |
CAZ | ≤2 | S |
MIC breakpoint reference: M100 in Clinical and Laboratory Standards Institute (CLSI). S – susceptible; MINO – minocycline; TMP-SMX – trimethoprim-sulfamethoxazole; LVFX – levofloxacin; CAZ – ceftazidime; MIC – minimum inhibitory concentration. |